The electronic patient record systems were identified through their statistical modules in a primary data retrieval including age and gender.
The historical nature of the present cohort was a particular limitation on the systematic analysis of behavioural deficits; for example, the nature of the naming impairment here remains ill-defined, and this could in principle reflect primary word retrieval, semantic or mixed deficits.
After the respective antigen retrieval, primary antibodies for Nrf2 and cell type-specific markers were applied simultaneously at 4 °C overnight.
Details about experimental procedures, primary antibodies, antigen retrieval detection systems and scoring are described elsewhere [ 12, 13, 27].
In brief, following heat-induced antigen retrieval, primary antibodies (Additional file 2) were incubated at 8° overnight.
Before incubation with the primary antibody, antigen retrieval was done by boiling the sections in 10 m M citrate buffer for 10 min using a microwave oven.
After antigen retrieval, primary antibody incubation was carried out overnight at 4 °C followed by incubation with secondary antibody for 30 60 min at room temperature.
Prior to application of primary antibody, antigen retrieval was performed by heating the sections in Tri-sodium citrate buffer [1.47 g Tri-sodium citrate (Sigma), 2.2 mL 1.0 M HCl (Sigma), and 500 mL distilled water at pH 6.0] for 30 seconds on high power in microwave (1000 W).
Despite comprehensive approaches to data identification and retrieval, primary data were limited for certain dietary factors, countries, and time periods: for example, more data were available for 2010 than 1990, and relatively little data were available in most Sub-Saharan African nations or for trans fats and plant omega 3 fats.
In brief, after deparaffinization, endogenous peroxidase block and heat-induced epitope retrieval, primary rabbit polyclonal antibody to Annexin A1 (product code of BA0640, Boster Biotech Co., Wuhan, China) at 1 150 dilution was added overnight at 4°C, then visualized using 3,3'-diaminobenzidine (DAB) detection kit (Dako Cytomation, Denmark).
